Aldeyra Therapeutics Inc (ALDX)
4.165
+0.04
(+1.09%)
USD |
NASDAQ |
May 07, 16:00
4.165
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Free Cash Flow: -30.86M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.86M |
| December 31, 2023 | -30.33M |
| September 30, 2023 | -42.06M |
| June 30, 2023 | -46.61M |
| March 31, 2023 | -53.21M |
| December 31, 2022 | -56.65M |
| September 30, 2022 | -57.00M |
| June 30, 2022 | -52.86M |
| March 31, 2022 | -41.97M |
| December 31, 2021 | -42.56M |
| September 30, 2021 | -39.30M |
| June 30, 2021 | -37.11M |
| March 31, 2021 | -35.61M |
| December 31, 2020 | -37.49M |
| September 30, 2020 | -40.40M |
| June 30, 2020 | -42.48M |
| March 31, 2020 | -47.72M |
| December 31, 2019 | -44.99M |
| September 30, 2019 | -41.75M |
| June 30, 2019 | -41.17M |
| March 31, 2019 | -34.66M |
| Date | Value |
|---|---|
| December 31, 2018 | -30.12M |
| September 30, 2018 | -27.17M |
| June 30, 2018 | -24.14M |
| March 31, 2018 | -23.14M |
| December 31, 2017 | -19.25M |
| September 30, 2017 | -18.13M |
| June 30, 2017 | -16.92M |
| March 31, 2017 | -14.87M |
| December 31, 2016 | -15.16M |
| September 30, 2016 | -14.26M |
| June 30, 2016 | -13.67M |
| March 31, 2016 | -12.04M |
| December 31, 2015 | -9.398M |
| September 30, 2015 | -8.008M |
| June 30, 2015 | -6.309M |
| March 31, 2015 | -5.556M |
| December 31, 2014 | -4.776M |
| September 30, 2014 | -3.770M |
| June 30, 2014 | -3.076M |
| March 31, 2014 | -2.472M |
| December 31, 2013 | -1.707M |
Free Cash Flow Range, Past 5 Years
-57.00M
Minimum
Sep 2022
-30.33M
Maximum
Dec 2023
-43.11M
Average
-42.02M
Median
Free Cash Flow Benchmarks
| AbbVie Inc | 21.89B |
| United Therapeutics Corp | 752.40M |
| Heron Therapeutics Inc | -60.33M |
| Esperion Therapeutics Inc | -135.49M |
| FibroGen Inc | -317.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.973M |
| Cash from Investing (Quarterly) | -30.38M |
| Cash from Financing (Quarterly) | 0.0182M |
| Free Cash Flow Per Share (Quarterly) | -0.1678 |
| Free Cash Flow Yield | -12.54% |